Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
1.440
-0.030 (-2.04%)
At close: Nov 3, 2025, 4:00 PM EST
1.400
-0.040 (-2.78%)
After-hours: Nov 3, 2025, 7:43 PM EST
Alector Market Cap
Alector has a market cap or net worth of $145.75 million as of November 3, 2025. Its market cap has decreased by -71.20% in one year.
Market Cap
145.75M
Enterprise Value
-122.05M
1-Year Change
-71.20%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since February 7, 2019, Alector's market cap has decreased from $1.23B to $145.75M, a decrease of -88.16%. That is a compound annual growth rate of -27.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 148.78M | -19.62% |
| Dec 31, 2024 | 185.09M | -72.43% |
| Dec 29, 2023 | 671.41M | -12.04% |
| Dec 30, 2022 | 763.34M | -54.52% |
| Dec 31, 2021 | 1.68B | 39.99% |
| Dec 31, 2020 | 1.20B | 0.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |